The global e-clinical solutions market size is expected to be worth around US$ 22.7 billion by 2030, according to a new report by Vision Research Reports.
The global e-clinical solutions market size was valued at US$ 7.9 billion in 2020 and is anticipated to grow at a CAGR of 13.7% during forecast period 2021 to 2030.
|Market Size||USD 22.7 Billion by 2030|
|Growth Rate||CAGR of 13.7% From 2021 to 2030|
|Forecast Period||2021 to 2030|
|Segments Covered||Product, delivery mode, development phase, end-use|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, Middle East & Africa|
|Companies Mentioned||Datatrak International, Inc.; Oracle; Parexel International Corporation; Dassault Systemes; Bioclinica; Datatrak International, Inc.; CRF Health; ERT Clinical; eClinicalWorks; IBM; Anju Life Sciences Software; eClinical Solutions|
Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth. During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage a huge influx of specimens on a daily basis.
Increasing research and development activities by biopharma and pharma companies is one of the key trends escalating market growth. Besides this, the growing incorporation of software solutions in clinical trials is also projected to drive the market for eClinical solutions.
By Product Analysis
The CTMS segment dominated the market for eClinical solutions and accounted for the largest revenue share of 20.9% in 2020. eCOA is estimated to be the fastest-growing segment during the forecast period owing to the rising significance of high-quality clinical data.
Elimination of data variance risk streamlined information and lowering of site monitoring cost are key advantages associated with eCOA. These aforementioned benefits are expected to fuel its demand in the coming years.
By Delivery Mode Analysis
The web-hosted segment dominated the market for eClinical solutions and accounted for the largest revenue share of around 75.2% in 2020. The dominance of the segment can be attributed to associated benefits such as easy accessibility, usability, and lower investments required.
The cloud-based segment is anticipated to exhibit an exponential CAGR of 14.3% during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup.
By Development Phase Analysis
On the basis of the development phase, the phase III segment dominated the market for eClinical solutions and accounted for the largest revenue share of 52.9% in 2020. The spiraling need for the incorporation of clinical data management software to curb overall cost and improve process efficiency is contributing to the growth of the segment.
The phase I segment is estimated to be the most promising segment during the forecast period owing to the high significance of these systems to predict future outcomes and eliminate drug candidates possessing the least probability of success.
By End-use Analysis
The CROs segment dominated the market for eClinical solutions and held the largest revenue share of 37.8% in 2020. The segment is projected to rise at a remarkable CAGR during the forecast period owing to the growing inclination of pharmaceutical companies to reduce overall expenditure.
Benefits involved in outsourcing clinical trials to CROs are responsible for the heightened growth of this segment. These benefits include cost advantages, increased efficiency of services, enhanced productivity, and a higher focus on core areas of development critical to a company’s growth.
By Regional Analysis
North America dominated the eClinical solutions market and accounted for the largest revenue share of 53.1% in 2020. The increasing target population, coupled with the rising prevalence of lifestyle-associated diseases such as diabetes and cardiac disorders, is poised to stimulate the growth of the market.
In Asia Pacific, the market for eClinical solutions is likely to register a noteworthy CAGR at 15.5% over the forecast period. High unmet medical needs and the rising prevalence of target chronic diseases such as cancer, cardiovascular conditions, and infectious diseases are stoking the demand for software solutions in the region
Datatrak International, Inc.
Parexel International Corporation
Datatrak International, Inc.
Anju Life Sciences Software
Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
Clinical Trial Management Systems (CTMS)
Clinical Analytics Platforms
Randomization and Trial Supply Management (RTSM)
Clinical Data Integration Platforms
Electronic Clinical Outcome Assessment (eCOA)
Electronic Trial Master File (eTMF)
By Delivery Mode
Web-hosted (On demand)
Licensed Enterprise (On premise)
By Development Phase
Pharma & Biotech Organizations
Medical Device Manufacturers
Central & South America
Middle East & Africa
The EClinical Solutions market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of EClinical Solutions market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global EClinical Solutions market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the EClinical Solutions market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted EClinical Solutions market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the EClinical Solutions capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of EClinical Solutions by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global EClinical Solutions market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major EClinical Solutions market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of EClinical Solutions market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the EClinical Solutions industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
EClinical Solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to EClinical Solutions market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of EClinical Solutions market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new EClinical Solutions market. These factors have benefited the growth of the global market for EClinical Solutions. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for EClinical Solutions. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of EClinical Solutions are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Non-Surgical Rhinoplasty Market (By Application: Indentations, Convex or concave nose, Asymmetry; By Type; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
U.S. Urgent Care Market (By Application: Acute Respiratory Infection, Injuries, Joint/Soft Tissue Issues; By Ownership) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Glaucoma Surgery Devices Market (By Product: Glaucoma Drainage Device, Laser System; By Surgery Method; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Transcatheter Aortic Valve Replacement Market (By Procedure: Transapical, Transfemoral, Transaortic)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Bioadhesive Wound Care Market (By Type: Fibrin Based Bioadhesive, PEG Based Bioadhesive, Cyanoacrylate Based Bioadhesive; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...